- Home
- DTIL vs SACH Comparison
DTIL vs SACH Comparison
Compare DTIL & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- SACH
- Stock Information
- Founded
- DTIL 2006
- SACH 2010
- Country
- DTIL United States
- SACH United States
- Employees
- DTIL N/A
- SACH N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- SACH Real Estate Investment Trusts
- Sector
- DTIL Health Care
- SACH Real Estate
- Exchange
- DTIL Nasdaq
- SACH Nasdaq
- Market Cap
- DTIL 55.3M
- SACH 54.4M
- IPO Year
- DTIL 2019
- SACH 2017
- Fundamental
- Price
- DTIL $4.96
- SACH $1.23
- Analyst Decision
- DTIL Strong Buy
- SACH Hold
- Analyst Count
- DTIL 2
- SACH 4
- Target Price
- DTIL $47.00
- SACH $2.25
- AVG Volume (30 Days)
- DTIL 84.3K
- SACH 126.8K
- Earning Date
- DTIL 08-07-2025
- SACH 08-05-2025
- Dividend Yield
- DTIL N/A
- SACH 16.13%
- EPS Growth
- DTIL N/A
- SACH N/A
- EPS
- DTIL N/A
- SACH N/A
- Revenue
- DTIL $1,261,000.00
- SACH N/A
- Revenue This Year
- DTIL N/A
- SACH N/A
- Revenue Next Year
- DTIL $135.19
- SACH $4.98
- P/E Ratio
- DTIL N/A
- SACH N/A
- Revenue Growth
- DTIL N/A
- SACH N/A
- 52 Week Low
- DTIL $3.61
- SACH $0.80
- 52 Week High
- DTIL $11.09
- SACH $2.70
- Technical
- Relative Strength Index (RSI)
- DTIL 56.59
- SACH 62.89
- Support Level
- DTIL $4.55
- SACH $1.15
- Resistance Level
- DTIL $4.99
- SACH $1.18
- Average True Range (ATR)
- DTIL 0.32
- SACH 0.04
- MACD
- DTIL 0.02
- SACH 0.01
- Stochastic Oscillator
- DTIL 81.11
- SACH 92.86
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.